Elena Toschi, Molly Savory, Colin Conery, Noa Krakoff, Atif Adam, Christine Slyne, Medha Munshi
{"title":"Impact of Simplification Strategies on Postmeal Glucose Excursions in Older Adults with Type 1 Diabetes and Hypoglycemia.","authors":"Elena Toschi, Molly Savory, Colin Conery, Noa Krakoff, Atif Adam, Christine Slyne, Medha Munshi","doi":"10.1177/15209156251370985","DOIUrl":null,"url":null,"abstract":"<p><p>Continuous glucose monitoring with simplification strategies reduces hypoglycemia in older adults with type 1 diabetes (T1D), however the impact on postmeal glycemia is not known. A post-hoc analysis of older adults with T1D randomized to intervention with mealtime simplification strategies, or control, assessed weekly postmeal hypoglycemia and hyperglycemia. At baseline, 88 older adults with T1D (71 ± 5 years) in intervention (n = 47) and control (n = 41) had similar number of episodes of postmeal hypo- and hyperglycemia. The mean decrease from baseline to 6 months in episodes of postmeal hypoglycemia was: after breakfast (-0.77 vs. -0.32; <i>P</i> = 0.02), lunch (-0.80 vs. -0.32; <i>P</i> = 0.05), and dinner (-0.73 vs. -0.22; <i>P</i> = 0.04); and the mean change in episodes of postmeal hyperglycemia was: after breakfast (-2.05 vs. -1; <i>P</i> = 0.04), lunch (-1.23 vs. -0.87; <i>P</i> = 0.09), and dinner (-1.45 vs. -1.66; <i>P</i> = 0.33), respectively in intervention and control. Simplification strategies in older adults with T1D resulted in fewer episodes of postmeal hypoglycemia without worsening episodes of postmeal hyperglycemia.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156251370985","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Continuous glucose monitoring with simplification strategies reduces hypoglycemia in older adults with type 1 diabetes (T1D), however the impact on postmeal glycemia is not known. A post-hoc analysis of older adults with T1D randomized to intervention with mealtime simplification strategies, or control, assessed weekly postmeal hypoglycemia and hyperglycemia. At baseline, 88 older adults with T1D (71 ± 5 years) in intervention (n = 47) and control (n = 41) had similar number of episodes of postmeal hypo- and hyperglycemia. The mean decrease from baseline to 6 months in episodes of postmeal hypoglycemia was: after breakfast (-0.77 vs. -0.32; P = 0.02), lunch (-0.80 vs. -0.32; P = 0.05), and dinner (-0.73 vs. -0.22; P = 0.04); and the mean change in episodes of postmeal hyperglycemia was: after breakfast (-2.05 vs. -1; P = 0.04), lunch (-1.23 vs. -0.87; P = 0.09), and dinner (-1.45 vs. -1.66; P = 0.33), respectively in intervention and control. Simplification strategies in older adults with T1D resulted in fewer episodes of postmeal hypoglycemia without worsening episodes of postmeal hyperglycemia.
连续血糖监测简化策略可降低老年1型糖尿病(T1D)患者的低血糖,但对餐后血糖的影响尚不清楚。一项针对老年T1D患者的事后分析,随机分为进餐时间简化干预组或对照组,评估每周餐后低血糖和高血糖。基线时,干预组(n = 47)和对照组(n = 41)的88名老年T1D患者(71±5岁)餐后低血糖和高血糖发作次数相似。从基线到6个月,餐后低血糖发作的平均减少是:早餐(-0.77 vs. -0.32, P = 0.02),午餐(-0.80 vs. -0.32, P = 0.05)和晚餐(-0.73 vs. -0.22, P = 0.04);干预组和对照组餐后高血糖发作次数的平均变化分别为:早餐后(-2.05 vs. -1, P = 0.04)、午餐后(-1.23 vs. -0.87, P = 0.09)、晚餐后(-1.45 vs. -1.66, P = 0.33)。老年T1D患者的简化策略导致餐后低血糖发作次数减少,且餐后高血糖发作没有恶化。
期刊介绍:
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.